Human scalp follicular unit mouse xenograft model
A novel xenograft model using human scalp follicular units implanted into GFP acid mice to study hair follicle biology and treatment efficacy.
Overview
The Human Scalp Follicular Unit Mouse Xenograft Model represents a cutting-edge approach to studying hair follicle biology and treatment efficacy. By implanting intact human scalp follicular units into GFP acid mice, this model allows for the detailed examination of hair follicle behavior and response under various treatment conditions. The model enables researchers to observe and analyze cellular activity at different levels of the follicle, providing valuable insights into hair growth and regeneration processes.
Technical specifications
- Implantation Method: Utilizes intact human scalp follicular units implanted into GFP acid mice.
- Analysis: Involves sectioning individual follicles horizontally and interrogating single populations of cells at various follicular levels.
- Treatment Evaluation: Facilitates the assessment of both topical and systemic treatments over time.
- Research Potential: Offers a platform for understanding hair follicle biology and developing new dermatological therapies.
Technology readiness level
This xenograft model is at a Technology Readiness Level 4. It has been validated through initial lab studies and requires further development and validation under the supervision of senior research personnel at The University of Melbourne.
About The University of Melbourne
The University of Melbourne is a comprehensive institution spanning STEM, health and clinical practice, business and law, and the creative and social disciplines. Co‑located hospital and research precincts, together with an inner‑city innovation ecosystem, place companies, startups, and researchers in shared labs, prototyping spaces, and studios. Engineering and technology programs connect with advanced manufacturing facilities, while structured industry projects and placements link partners with talent and translational problem‑solving. Work is supported by competitive funding from the Australian Research Council and the National Health and Medical Research Council, with additional backing from state programs and industry partners; a dedicated technology transfer office manages IP, licensing, and startup formation.
delivered to your inbox.